Receiving a transplant represents hope, but long-term success depends on far more than surgery alone.
The ESOT–Takeda collaboration, outlined in the September 2025 report Enhancing Post-Transplant Care, demonstrates how person-centred care and infectious disease educationcan reshape outcomes across Europe.
Moving Beyond the Organ Post-transplant care must address:
- Infection risk (including CMV and multidrug-resistant organisms)
- Emotional and psychological adaptation
- Patient literacy and health navigation
- Long-term quality of life
The guiding principle is simple yet transformative: “A life that is gained should also be lived.”
Empowering Patients: The My Life My Health Toolkit
The multilingual toolkit provides:
- Educational booklets and workbooks for recipients
- Resources for families
- Structured guidance for healthcare professionals
- Tools that promote dialogue, adaptation and balance
- Workshops across London, Barcelona and Bologna have trained healthcare professionals to implement person-centred care in real clinical settings.
- Advancing Infectious Disease Standards
The collaboration also strengthens medical education through:
- Workshops on CMV-resistant infections
- Arbovirus risk awareness
- An ESOT-certified education pathway
Year 3 (2025-2026) introduces:
- A European CMV practice survey update
- Consensus and position papers
- A prospective clinical data study
- A Transplant Equity Study and policy summit
A Model for Future Partnerships
This collaboration illustrates how scientific societies and industry can align expertise to drive measurable impact, improving survival, equity and quality of life.
Read the full report here.
This project has been funded by Takeda. ESOT developed the content of this report independently. Takeda reviewed the manuscript for factual accuracy only.